TY - JOUR
T1 - Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients
AU - Kale, Anvita
AU - Joshi, Sadhana
AU - Naphade, Nilesh
AU - Sapkale, Swati
AU - Raju, M. S.V.K.
AU - Pillai, Anilkumar
AU - Nasrallah, Henry
AU - Mahadik, Sahebarao P.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2008/1
Y1 - 2008/1
N2 - Variable levels of essential polyunsaturated fatty acids (EPUFAs) reported in schizophrenia are likely due to differences in age, sex, ethnicity, diet, life style and treatments. The present study examined the EPUFAs levels in plasma, RBC and CSF in never-medicated first-episode psychotic patients and normal controls matched for ethnicity, diet and life style. The plasma EPUFAs levels were similar in both groups. Among the EPUFAs enriched in the brain, predominantly docosahexaenoic acid (DHA) levels were lower in RBC (p = < 0.01) whereas higher in CSF (p = < 0.01) in male > female patients. This altered DHA metabolism may provide clues for neuropathology and treatment of schizophrenia.
AB - Variable levels of essential polyunsaturated fatty acids (EPUFAs) reported in schizophrenia are likely due to differences in age, sex, ethnicity, diet, life style and treatments. The present study examined the EPUFAs levels in plasma, RBC and CSF in never-medicated first-episode psychotic patients and normal controls matched for ethnicity, diet and life style. The plasma EPUFAs levels were similar in both groups. Among the EPUFAs enriched in the brain, predominantly docosahexaenoic acid (DHA) levels were lower in RBC (p = < 0.01) whereas higher in CSF (p = < 0.01) in male > female patients. This altered DHA metabolism may provide clues for neuropathology and treatment of schizophrenia.
KW - Arachidonic acid
KW - Cerebrospinal fluid
KW - Docosahexaenoic acid
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=37049002256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=37049002256&partnerID=8YFLogxK
U2 - 10.1016/j.schres.2007.09.036
DO - 10.1016/j.schres.2007.09.036
M3 - Article
C2 - 17997280
AN - SCOPUS:37049002256
SN - 0920-9964
VL - 98
SP - 295
EP - 301
JO - Schizophrenia Research
JF - Schizophrenia Research
IS - 1-3
ER -